Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/105282
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Time to clinical investigation for Indigenous and non-Indigenous Queensland women after a high grade abnormal Pap smear, 2000-2009
Author: Whop, L.
Baade, P.
Brotherton, J.
Canfell, K.
Cunningham, J.
Gertig, D.
Lokuge, K.
Garvey, G.
Moore, S.
Diaz, A.
O'Connell, D.
Valery, P.
Roder, D.
Condon, J.
Citation: Medical Journal of Australia, 2017; 206(2):73-77
Publisher: Australasian Medical Publishing Company
Issue Date: 2017
ISSN: 0025-729X
1326-5377
Statement of
Responsibility: 
Lisa J Whop, Peter D Baade, Julia ML Brotherton, Karen Canfell, Joan Cunningham, Dorota Gertig, Kamalini Lokuge, Gail Garvey, Suzanne P Moore, Abbey Diaz, Dianne L O’Connell, Patricia Valery, David M Roder, John R Condon
Abstract: To investigate time to follow-up (clinical investigation) for Indigenous and non-Indigenous women in Queensland after a high grade abnormality (HGA) being detected by Pap smear.Population-based retrospective cohort analysis of linked data from the Queensland Pap Smear Register (PSR), the Queensland Hospital Admitted Patient Data Collection, and the Queensland Cancer Registry. 34 980 women aged 20-68 years (including 1592 Indigenous women) with their first HGA Pap smear result recorded on the PSR (index smear) during 2000-2009 were included and followed to the end of 2010.Time from the index smear to clinical investigation (histology test or cancer diagnosis date), censored at 12 months.The proportion of women who had a clinical investigation within 2 months of a HGA finding was lower for Indigenous (34.1%; 95% CI, 31.8-36.4%) than for non-Indigenous women (46.5%; 95% CI, 46.0-47.0%; unadjusted incidence rate ratio [IRR], 0.65; 95% CI, 0.60-0.71). This difference remained after adjusting for place of residence, area-level disadvantage, and age group (adjusted IRR, 0.74; 95% CI, 0.68-0.81). However, Indigenous women who had not been followed up within 2 months were subsequently more likely to have a clinical investigation than non-Indigenous women (adjusted IRR for 2-4 month interval, 1.21; 95% CI, 1.08-1.36); by 6 months, a similar proportion of Indigenous (62.2%; 95% CI, 59.8-64.6%) and non-Indigenous women (62.8%; 95% CI, 62.2-63.3%) had been followed up.Prompt follow-up after a HGA Pap smear finding needs to improve for Indigenous women. Nevertheless, slow follow-up is a smaller contributor to their higher cervical cancer incidence and mortality than their lower participation in cervical screening.
Keywords: Humans; Mass Screening; Aftercare; Incidence; Retrospective Studies; Time Factors; Adult; Aged; Middle Aged; Oceanic Ancestry Group; Delivery of Health Care; Queensland; Uterine Cervical Neoplasms; Female; Papanicolaou Test
Rights: © 2017 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved.
RMID: 0030064811
DOI: 10.5694/mja16.00255
Grant ID: http://purl.org/au-research/grants/nhmrc/1045591
http://purl.org/au-research/grants/nhmrc/1055587
http://purl.org/au-research/grants/nhmrc/1058244
http://purl.org/au-research/grants/nhmrc/1083090
http://purl.org/au-research/grants/nhmrc/1082989
Appears in Collections:Public Health publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.